Induced Infringement And Price Fixing Among Legal Headlines In 2021

US Supreme Court Issues Key Decision Against Sandoz On Enbrel

In 2021, courts across the US and beyond continued to weigh key patent litigation fights, alongside the thorny issue of induced infringement via label carve outs and controversial charges for generic price fixing.

US-Supreme-Court_V2_1200
The US Supreme Court denied Sandoz' bid for a review of Enbrel IP • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin